May 13, 2020
Illumina Inc. and Natera Inc. have agreed to drop dueling patent infringement claims over fetal DNA testing technology in California federal court and to firm up a licensing agreement, according to a newly submitted regulatory filing.
June 26, 2018
A California federal judge on Tuesday refused to toss Illumina Inc.'s patent infringement litigation against rival Natera Inc., finding that there was not enough evidence yet to show whether Illumina's fetal DNA testing technology covers the type of natural phenomenon that would be unpatentable under Mayo.
May 18, 2018
Natera Inc. on Thursday asked a California federal court to free it from patent infringement litigation brought by competitor Illumina Inc., arguing the fetal DNA testing technology at issue isn't patent eligible because it covers naturally occurring phenomena.